Ziyi Lu

623 total citations
30 papers, 363 citations indexed

About

Ziyi Lu is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Ziyi Lu has authored 30 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Surgery. Recurrent topics in Ziyi Lu's work include Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Advancements in Transdermal Drug Delivery (4 papers) and Advanced Drug Delivery Systems (3 papers). Ziyi Lu is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Advancements in Transdermal Drug Delivery (4 papers) and Advanced Drug Delivery Systems (3 papers). Ziyi Lu collaborates with scholars based in China, Hong Kong and Thailand. Ziyi Lu's co-authors include Zhen Gu, Jicheng Yu, Jiahao Hu, Mingyu Chen, Win Topatana, Shijie Li, Jiasheng Cao, Yuqi Zhang, Hanqi Zheng and Sarun Juengpanich and has published in prestigious journals such as Advanced Materials, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Ziyi Lu

29 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ziyi Lu China 10 104 91 84 52 38 30 363
Sam Osseiran United States 10 126 1.2× 59 0.6× 116 1.4× 37 0.7× 22 0.6× 18 420
Fereshteh Abbasvandi Iran 13 205 2.0× 30 0.3× 166 2.0× 40 0.8× 26 0.7× 43 527
Leilei Bao China 13 199 1.9× 147 1.6× 209 2.5× 34 0.7× 33 0.9× 35 572
Yihui Chen China 9 88 0.8× 21 0.2× 65 0.8× 71 1.4× 51 1.3× 32 299
Chenghao Liu China 14 130 1.3× 221 2.4× 253 3.0× 37 0.7× 71 1.9× 34 770
Shuzhan Shen China 8 210 2.0× 57 0.6× 86 1.0× 92 1.8× 109 2.9× 21 402
Seong Dong Jeong South Korea 11 87 0.8× 71 0.8× 172 2.0× 47 0.9× 22 0.6× 19 441
Míchel Herranz Spain 11 73 0.7× 75 0.8× 61 0.7× 40 0.8× 11 0.3× 24 363
Mohammad Ali Khayamian Iran 10 135 1.3× 31 0.3× 67 0.8× 10 0.2× 33 0.9× 28 258
Shallu Kutlehria United States 12 158 1.5× 103 1.1× 114 1.4× 13 0.3× 18 0.5× 16 398

Countries citing papers authored by Ziyi Lu

Since Specialization
Citations

This map shows the geographic impact of Ziyi Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziyi Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziyi Lu more than expected).

Fields of papers citing papers by Ziyi Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziyi Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziyi Lu. The network helps show where Ziyi Lu may publish in the future.

Co-authorship network of co-authors of Ziyi Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Ziyi Lu. A scholar is included among the top collaborators of Ziyi Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziyi Lu. Ziyi Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Topatana, Win, Shijie Li, Jiadong Chen, et al.. (2025). Targeted Intracellular Copper Reservoir Enhances Liver Cancer Immunotherapy. Small. 21(36). e02783–e02783. 3 indexed citations
2.
Wang, Hao, Shenqiang Wang, Yinxian Yang, et al.. (2025). A wearable transdermal device for on-demand drug delivery. Matter. 8(4). 102040–102040. 9 indexed citations
4.
Peng, Bo, Yuejian Mao, Ziyi Lu, et al.. (2025). Comparative analysis of strong-flavor Baijiu and brandy: volatile and nonvolatile metabolic compounds identified using non-targeted metabolomics. European Food Research and Technology. 251(6). 1225–1239. 4 indexed citations
5.
Lu, Ziyi, et al.. (2025). A Comparative Study on Physicochemical and Analytical Characterizations of Doxil® and its Generic Drug Products. The AAPS Journal. 27(4). 100–100. 1 indexed citations
6.
Jiang, Yueyue, Xin Gu, Ziyi Lu, et al.. (2025). Effects of chromosome number reduction on mitotic and meiotic stability in fission yeast. Genome biology. 26(1). 232–232. 1 indexed citations
8.
Cai, Wenchao, Yuejian Mao, Ziyi Lu, et al.. (2024). Impact of Lactobacillus plantarum fermentation on jujube juice: Insights from intelligent sensory evaluation, tolerance index, and acidogenic potential. LWT. 217. 117185–117185. 8 indexed citations
9.
Juengpanich, Sarun, Shijie Li, Jiadong Chen, et al.. (2023). Pre-activated nanoparticles with persistent luminescence for deep tumor photodynamic therapy in gallbladder cancer. Nature Communications. 14(1). 5699–5699. 66 indexed citations
10.
Cao, Jiasheng, Win Topatana, Jiahao Hu, et al.. (2023). Evaluation of PD-L1 as a Biomarker for Immunotherapy for Hepatocellular Carcinoma: Systematic Review and Meta-Analysis. Immunotherapy. 15(5). 353–365. 8 indexed citations
11.
Cao, Jiasheng, Jia-Fei Yan, Jiahao Hu, et al.. (2023). Estimating the influencing factors for T1b/T2 gallbladder cancer on survival and surgical approaches selection. Cancer Medicine. 12(16). 16744–16755. 3 indexed citations
12.
Lu, Ziyi, et al.. (2023). Microneedle-based transdermal detection and sensing devices. Lab on a Chip. 23(5). 869–887. 77 indexed citations
13.
Chen, Mingyu, Sarun Juengpanich, Shijie Li, et al.. (2022). Bortezomib‐Encapsulated Dual Responsive Copolymeric Nanoparticles for Gallbladder Cancer Targeted Therapy. Advanced Science. 9(7). e2103895–e2103895. 26 indexed citations
14.
Hu, Jiahao, Jiasheng Cao, Renan Jin, et al.. (2022). Inhibition of AMPK/PFKFB3 mediated glycolysis synergizes with penfluridol to suppress gallbladder cancer growth. Cell Communication and Signaling. 20(1). 105–105. 5 indexed citations
15.
Lu, Ziyi, Win Topatana, Sarun Juengpanich, et al.. (2022). DNA damage response inhibition‐based combination therapies in cancer treatment: Recent advances and future directions. SHILAP Revista de lepidopterología. 3(1). 44–67. 4 indexed citations
16.
Cao, Jiasheng, Jiahao Hu, Jiliang Shen, et al.. (2022). Identification of publication characteristics and research trends in the management of gallbladder cancer. PubMed. 1(2). 127–138. 1 indexed citations
17.
Cao, Jiasheng, Jiahao Hu, Renan Jin, et al.. (2022). Identification of invasion-metastasis associated MiRNAs in gallbladder cancer by bioinformatics and experimental validation. Journal of Translational Medicine. 20(1). 188–188. 11 indexed citations
18.
Cao, Jiasheng, Jiahao Hu, Win Topatana, et al.. (2022). Enhanced Recovery Care vs. Traditional Care in Laparoscopic Hepatectomy: A Systematic Review and Meta-Analysis. Frontiers in Surgery. 9. 850844–850844. 3 indexed citations
19.
Cao, Jiasheng, Bin Zhang, Jiahao Hu, et al.. (2021). Comparison of Outcomes After Primary Laparoscopic Versus Open Approach for T1b/T2 Gallbladder Cancer. Frontiers in Oncology. 11. 758319–758319. 11 indexed citations
20.
Cao, Jiasheng, Ziyi Lu, Mingyu Chen, et al.. (2021). Artificial intelligence in gastroenterology and hepatology: Status and challenges. World Journal of Gastroenterology. 27(16). 1664–1690. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026